Individual pharmacokinetic variability, including differences in drug absorption, distribution, and elimination, contributes to the wide range of experiences patients report
Under normal circumstances, it focuses on manufacturing relatively small quantities of drugs for specialized cases where a patient cant take a mass-produced drug due to some medical condition
This work was supported by the Helmholtz Association, the German Centre for Lung Research (DZL), the Ministry of Health of the Czech republic (grant number NT 13433-4/2012, IGA MZR), and the Max-Planck Society for the Advancement of Science
The loading doses are generally smaller, fractionated injections designed to steadily increase receptor exposure without overwhelming the system in a single large bolus
L., & Rubio-Herrera, M
The impact of readmission/reoperation on morbidity for patients after LHM is unknown